Subscribe to RSS
DOI: 10.1055/s-0037-1620653
Loss of Thyroid Hormones into Feces in Children on Regular Hemodialysis
Fäkaler Verlust von Schilddrüsenhormonen bei Hämodialyse-KindemPublication History
Received:19 May 1981
Publication Date:
10 January 2018 (online)
In 20 children on hemodialysis in vitro tests of thyroid function were made. Total T4, free T4 and total T3 were below the normal mean. The daily loss of T3 into feces was significantly higher in dialysis children than in healthy controls. The loss of T4 into feces was somewhat higher in dialysis children than in healthy controls. The amount of hormonal iodine loss into feces was calculated. It was significantly higher in children on hemodialysis than in controls. It is concluded that the loss of thyroid hormones into feces is the major cause of low serum thyroid hormone levels in children on hemodialysis.
Bei 20 Hämodialysekindern wurden die in vitro Werte zur Beurteilung der Schilddrüsenfunktion bestimmt. Gesamt-T4, freies T4 und Gesamt-T3 waren niedriger als die mittleren Serumkonzentrationen. Der tägliche fäkale Verlust an T3 war bei Dialysekindern signifikant höher als bei gesunden Kindern. Der Verlust an T4 war etwas höher in der Gruppe der Dialysekinder als in der Kontrollgruppe. Die Menge des fäkalen Verlustes an Hormonjod wurde berechnet. Sie war bei Dialysekindern signifikant höher als in der Kontrollgruppe. Es wird angenommen, daß der Verlust von Schilddrüsenhormonen in den Stuhl die Hauptursache für die niedrigen Schilddrüsenhormonkonzentrationen im Serum von Dialysekindern ist.
-
Literature
- 1 Beyer H.-K, Schuster P, Pressler H. Schilddrüsenfunktion bei dialysepflichtiger Niereninsuffizienz. Nucl. Med 19: 283 1980;
- 2 Benua R.S, Albert A, Keating F.R. The metabolism of radiothyroxine in exophthalmic goiter. J. clin. Endocrinol 12: 1461 1952;
- 3 Berson S.A, Yalow R. S. Quantitative aspects of iodine metabolism. The exchangeable organic iodine pool, and the rates of thyroidal secretion, peripheral degradation and fecal excretion of endogenously synthezised organically bound iodine. J. clin. Invest 33: 1533 1954;
- 4 Bratusch M.P, Kopsa H, Pils P, Waldhäusl W, Zazgornik J, Schmidt P. Persistent pituitary-thyroid dysfunction in patients following renal transplantation. Clin. Nephrol 14: 66 1980;
- 5 Chan J.C.M. Hemodialysis and thyroid function in children. J. Dialysis 2: 387 1978;
- 6 Chopra I. J, Chopra U, Smith S. R. Reciprocal changes in serum concentrations of 3,3′-5′-triiodo-thyronine (reverse T3) and 3,3′-5-triiodothyronine(T3) in systemic illness. J. clin. Endocrinol. Metab 41: 1043 1975;
- 7 Czernichow P, Danzet M.C, Broyer M, Rap-paport R. Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure. J. clin. Endocr. Metab 43: 630 1976;
- 8 Dandona P, Newton D, Platts M.M. Long-term haemodialysis and thyroid function. Brit. med. J 1: 134 1977;
- 9 Fankhauser S, Huber D, Studer H. Zur Beurteilung der Schilddrüsenfunktion bei Patienten mit Niereninsuffizienz. Schweiz. med. Wschr 98: 698 1968;
- 10 Feldman H.A, Singer I. Endocrinology and metabolism in uremia and dialysis: A clinical review. Medicine 54: 345 1974;
- 11 Hays M.T. Absorption of oral thyroxine in man. J. clin. Endocr 28: 749 1968;
- 12 Hays M.T. Absorption of triiodothyronine in man. J. clin. Endocr 30: 675 1970;
- 13 Hershman J.M, Krugmann L.G, Kopple I.D, Reed A.W, Azukizawa M, Shinaberger J. H. Thyroid function in patients undergoing maintenance hemodialysis: Unexplained low serum thyroxine concentration. Metabolism 27: 755 1978;
- 14 Jaosoo A, Murray I.P.C, Parkin J, Robertson M.R, Jeremy D. Abnormalities of in vitro thyroid function tests in renal disease Quart. J. Med 43: 245 1974;
- 15 Kalk W.J, Marley J.E, Gold C.H, Meyers A. Thyroid function tests in patients on regular hemodialysis. Nephron 25: 173 1980;
- 16 Karunanichhi A, Kanagasabapathy A.S, Shastry J.C.M, Kosky T.S. Thyroid function in patients with chronic renal failure. Indian J. med. Res 69/5: 792 1979;
- 17 König J. Die alimentäre Jodversorgung im Raum Köln. Inauguraldissertation, Medizinische Fakultät der Universität zu Köln. 1979
- 18 Kolendorf K, Moller B.B, Rogowski P. The influence of chronic renal failure on serum and urinary thyroid hormone levels. Acta Endocr 89: 80 1978;
- 19 Kosowicz J, Malczewska B, Czekalski S. Serum reserve triiodothyronine (3,3′-5′-l-triiodothyronine) in chronic renal failure. Nephron 26: 85 1980;
- 20 Miller L.J, Gorman C.A, Go V.L.W. Gut thyroid interrelationships. Gastroenterology 75: 901 1978;
- 21 Neuhaus K, Baumann G, Walser H, Thölen H. Serum thyroxine and thyroxine-binding proteins in chronic renal failure without nephrosis. J. clin. Endocr. Metab 41: 395 1975;
- 22 Oddie T.H, Flanigan W.J, Fisher D.A. Iodine and thyroxine metabolism in nephric patients receiving chronic peritoneal dialysis. J. clin. Endocr. Metab 31: 277 1970;
- 23 Rasmussen H. Thyroxine metabolism in the nephrotic syndrome. J. clin. Invest 35: 792 1956;
- 24 Savdie E, Steward J.H, Mahony J.F, Hayes J.M, Lazarus L, Simons L.A. Circulating thyroid hormone levels and adequacy of dialysis. Clin. nephrol 9: 68 1978;
- 25 Silverberg D.S, Ulan R.A, Fawcett D.M, Dossetor J.B, Grace M, Bettcher K. Effects of chronic hemodialysis on thyroid function in chronic renal failure. Can. med. Assoc. J 109: 282 1973;
- 26 Spector D.A, Davis P.J, Helderman J.H, Bell B, Utiger R. D. Thyroid function and metabolic state in chronic renal failure. Ann. int. Med 85: 724 1976;
- 27 Waters W, Mödder G, Krappitz N, Kutzim H, Glöckner D. Klinische Bedeutung der direkten Bestimmung der freien Thyroxinkonzentration im Serum. NUC-Compact 4: 115 1979;